Our results showed that the expression of LC3 and ATG5 mRNA was significantly increased in B16 melanoma cells treated by the CAP, whereas CAP-treated non-malignant L929 cells showed an appreciable reduction in the expression of autophagic-related genes. The gene discussed is MAP1LC3A; the disease is melanoma.